Evidence map›Paper›PMID 41963784›Full record

ArticleBMC bioinformatics2026

Molecular contrastive learning with graph attention network (MoCL-GAT) for enhanced molecular representation.

Alperen Dalkıran, Ahmet Sureyya Rifaioglu, Rengul Cetin-Atalay, Aybar C Acar, Tunca Doğan, M Volkan Atalay

Abstract read
In one paragraph

Article in BMC bioinformatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Alperen DalkıranDepartment of Computer Engineering, Middle East Technical University, 06800, Ankara, Turkey. dalkiran@ceng.metu.edu.tr.
Ahmet Sureyya RifaiogluFaculty of Medicine, and Heidelberg University Hospital, Institute for Computational Biomedicine, Heidelberg University, Heidelberg, Germany.ORCID http://orcid.org/0000-0001-6717-4767
Rengul Cetin-AtalayDepartment of Medicine, Section of Pulmonary and Critical Care Medicine, The University of Chicago, Chicago, IL, 60637, USA.
Aybar C AcarCancer Systems Biology Laboratory (KanSiL), Graduate School of Informatics, Middle East Technical University, 06800, Ankara, Turkey.
Tunca DoğanBiological Data Science Lab, Department of Computer Engineering, Hacettepe University, 06800, Ankara, Turkey.
M Volkan AtalayDepartment of Information Systems and Supply Chain Management, Loyola University Chicago, Chicago, IL, 60611, USA.

Funding

Türkiye Bilimsel ve Teknolojik Araştırma Kurumu 121E208
6 · The paper itself

Abstract

backgroundLearning the representation of molecules is crucial for drug discovery but is often hindered by the scarcity of labeled experimental data, which limits the performance of supervised machine learning models. While self-supervised learning (SSL) offers a solution by leveraging vast unlabeled chemical databases, many existing methods focus on learning from either local structural information or global molecular properties, but not both simultaneously. We introduce MoCL-GAT, a novel contrastive and transfer learning-based SSL framework that addresses this gap by simultaneously learning from two complementary objectives. It combines a local contrastive task on molecular subgraphs to capture fine-grained chemical environments with a global predictive task to learn holistic molecular descriptors. This dual-objective approach, powered by a Graph Attention Network, is designed to create more robust, versatile, and transferable molecular representations.

resultsPre-trained on 1.9 million compounds, MoCL-GAT was fine-tuned on diverse benchmarks. It achieved state-of-the-art performance on molecular property prediction tasks, with an AUROC of 0.928 on BBBP and 0.768 on SIDER, and top-ranking RMSEs of 0.570 for ESOL and 1.818 for FreeSolv. Critically, fine-tuned models consistently and significantly outperformed models trained from scratch, confirming the value of pre-training.

conclusionsThese results validate that MoCL-GAT's dual-objective approach learns highly effective and transferable representations, enabling more accurate and data-efficient predictions for key cheminformatics challenges. The source code for MoCL-GAT is publicly available on Zenodo at https://doi.org/10.5281/zenodo.16927285 .

Indexed as

Drug DiscoveryMachine LearningDatabases, ChemicalGraph Neural NetworksSupervised Machine LearningTransfer Machine LearningArtificial intelligenceDeep learningDrug discoveryGraph theoryMachine learning

Identifiers

PMID41963784
PMCPMC13185379

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.